Menu

Latest news & events

Social and economic background influences survival in intensive care: Research with societal impact

Social and economic background influences survival in intensive care: Research with societal impact

18 August 2026

A large-scale study by researchers from Maastricht UMC+ and Amsterdam UMC demonstrates that lower socioeconomic status (SES) of patients admitted to Dutch intensive care units contributes to worse survival.

Read more
Fatma Karapinar appointed as Professor in Medication Safety

Fatma Karapinar appointed as Professor in Medication Safety

12 August 2026

As of 1 June 2026, Dr Fatma Karapinar has been appointed Professor of Medication Safety at Maastricht University.

Read more
More newsMore events
Carim Maastricht
Carim Maastricht

Erik Beckers

Professor

Prof. Erik Beckers studied medicine at the University of Maastricht and graduated with honour in 1988. His first career started in transfusion medicine focussing his scientific research on blood group antigens, more specifically RhD variants, at the Blood Bank in Maastricht and Central Laboratory for Blood Transfusion in Amsterdam (now Sanquin Blood Bank and Sanquin Research). In 1997, he defended his PhD thesis titled ‘Serological and genomic studies on RhD antigens’ at the University of Amsterdam.

In 2002, he was registered as internist after clinical training in Amsterdam and Rotterdam, followed by registration as transfusion medicine specialist in 2003 (Sanquin Blood Bank Rotterdam). From 2002 until 2007, he has worked as transfusion medicine specialist in the diagnostic reference laboratory for red cell serology at Sanquin Rotterdam.

From 2007 until 2009, Dr Beckers has continued his medical training in hematology (Haga Hospital The Hague and Maastricht University Medical Centre). From 2009, he has been holding a position as internist-hematologist and consultant for Hemostasis and Transfusion at Maastricht UMC+. Main areas of interests are congenital and acquired bleeding tendencies and improving prevention of bleeding in hemato-oncological patients. His research activities are concentrated around the theme: ‘predictors of bleeding’, in search of improved determinants of bleeding risks in congenital bleeding disorders and in patients with chemotherapy induced thrombocytopenia, establishing novel diagnostic algorithms in bleeding tendencies.

Erik-beckers

Department of Internal Medicine
Universiteitsingel 50, 6229 ER Maastricht
PO Box 616, 6200 MD Maastricht
T: +31 (0)43 387 65 43

  • 2026
    • El Idrissi, A., Korver-keularts, I. M. L. W., Straat, R. J. M. H. E., & Beckers, E. A. M. (2026). Liberal versus restrictive transfusion in haemato-oncological patients undergoing autologous stem cell transplantation: A single-centre experience. Transfusion Medicine. Advance online publication. https://doi.org/10.1111/tme.70078
  • 2025
    • Monard, A. L. L., Hellenbrand, D., Verhezen, P., Beckers, E. A. M., Henskens, Y. C. M., & Heubel-Moenen, F. C. J. I. (2025). tPA-ROTEM identifies hyperfibrinolytic profile in a significant proportion of patients with bleeding disorder of unknown cause (BDUC). Thrombosis Research, 253, Article 109404. https://doi.org/10.1016/j.thromres.2025.109404
    • van Lieshout, R., Tick, L. W., Beckers, E. A. M., Biesbroek, W., Custers, S., Dieleman, J. P., Dijkstra, M., Groenesteijn, W., Heldens, A., Hengeveld, M. M., Koene, H. R., Kranenburg, S., van der Lee, D., van der Put, L., Rademakers, N., Regelink, J. C., Regis, M., Somer, M., van Tilborg, C. J., ... Beijer, S. (2025). Associations of various medical nutrition therapy strategies with body composition, and physical and clinical outcomes in acute myeloid leukemia patients undergoing intensive remission-induction treatment: a multicenter prospective correlational study. Clinical Nutrition ESPEN, 67, 276-295. https://doi.org/10.1016/j.clnesp.2025.02.028
    • Olieslagers, T. I., Groeneweg, M., van Gorkom, G. N. Y., Beckers, E. A. M., Wieten, L., & Voorter, C. E. M. (2025). Somatic Genomic Alterations in Haematological Tumours Can Interfere With Accurate HLA and Chimerism Diagnostics. HLA, 105(3), Article e70093. https://doi.org/10.1111/tan.70093
  • 2024
    • van Lieshout, R., Tick, L. W., Beckers, E. A. M., Biesbroek, W., Dieleman, J. P., Dijkstra, M., Groenesteijn, W., Koene, H. R., Kranenburg, S., van der Lee, D., van der Put-van den Berg, L., Rademakers, N., Regelink, J. C., van Tilborg, C. J., Westerweel, P. E., de Zeeuw, S., Schouten, H. C., & Beijer, S. (2024). Changes in nutritional status and associations with physical and clinical outcomes in acute myeloid leukemia patients during intensive chemotherapy. European Journal of Clinical Nutrition, 78(12), 1082-1094. https://doi.org/10.1038/s41430-024-01488-8
    • Monard, A., Castoldi, E., De Simone, I., Wichapong, K., van Duijl, T., van den Biggelaar, M., Spada, S., van Doorn, W., Hellenbrand, D., van der Meijden, P., Swieringa, F., Stork, A., ten Cate, H., Beckers, E., Heubel-Moenen, F., & Henskens, Y. (2024). Case Report: Laboratory detection of a thrombotic tendency in a family with hypodysfibrinogenemia and a novel FGG mutation. Frontiers in Cardiovascular Medicine, 11, Article 1488602. https://doi.org/10.3389/fcvm.2024.1488602
    • Oomen, I., Verhagen, M., Miranda, M., Allacher, P., Beckers, E. A. M., Blijlevens, N. M. A., van der Bom, J. G., Coppens, M., Driessens, M., Eikenboom, J. C. J., Fijnvandraat, K., Hassan, S., van Heerde, W. L., Hooimeijer, H. L., Jansen, J. H., Kaijen, P., Leebeek, F. W. G., Meijer, D., Paul, H., ... Gouw, S. C. (2024). The spectrum of neutralizing and non-neutralizing anti-FVIII antibodies in a nationwide cohort of 788 persons with hemophilia A. Frontiers in Immunology, 15, Article 1355813. https://doi.org/10.3389/fimmu.2024.1355813
  • 2023
    • Van de Berg, T. W., Beckers, E. A. M., Heubel-Moenen, F. C. J. I., Henskens, Y. M. C., Thomassen, M. C. L. G. D., & Hackeng, T. M. (2023). Sensitive Measurement of Clinically Relevant Factor VIII Levels in Thrombin Generation Assays Requires Presence of Factor XIa. Thrombosis and Haemostasis, 123(11), 1034-1041. https://doi.org/10.1055/a-2101-7961
    • van Lieshout, R., Tick, L. W., de Beer, F., Koene, H. R., Regelink, J. C., Westerweel, P. E., de Witte, M. A., Beckers, E. A. M., Schouten, H. C., & Beijer, S. (2023). Medical nutrition therapy during intensive remission-induction treatment and hematopoietic stem cell transplantation in acute myeloid leukemia patients: Hematologists’ experiences and perspectives. Clinical Nutrition ESPEN, 57(1), 399-409. https://doi.org/10.1016/j.clnesp.2023.07.015
    • Heubel-Moenen, F. C. J. I., Ansems, L. E. M., Verhezen, P. W. M., Wetzels, R. J. H., van Oerle, R. G. M., Straat, R. J. M. H. E., Megy, K., Downes, K., Henskens, Y. M. C., Beckers, E. A. M., & Joore, M. A. (2023). Effectiveness and costs of a stepwise versus an all-in-one approach to diagnose mild bleeding disorders. British Journal of Haematology, 200(6), 792-801. https://doi.org/10.1111/bjh.18570
    • Verhagen, M. J. A., van Heerde, W. L., van der Bom, J. G., Beckers, E. A. M., Blijlevens, N. M. A., Coppens, M., Gouw, S. C., Jansen, J. H., Leebeek, F. W. G., van Vulpen, L. F. D., Meijer, D., & Schols, S. E. M. (2023). In patients with hemophilia, a decreased thrombin generation profile is associated with a severe bleeding phenotype. Research and practice in thrombosis and haemostasis, 7(2), Article 100062. https://doi.org/10.1016/j.rpth.2023.100062
  • 2022
    • van de Berg, T. W., Mulder, M. M. G., Alnima, T., Nagy, M., van Oerle, R., Beckers, E. A. M., Hackeng, T. M., Hulshof, A. M., Sels, J. W. E. M., Henskens, Y. M. C., van der Horst, I. C. C., ten Cate, H., Spronk, H. M. H., van Bussel, B. C. T., & Dutch COVID & Thrombosis Coalition (2022). Serial thrombin generation and exploration of alternative anticoagulants in critically ill COVID-19 patients: Observations from Maastricht Intensive Care COVID Cohort. Frontiers in Cardiovascular Medicine, 9, Article 929284. https://doi.org/10.3389/fcvm.2022.929284
    • Zwagemaker, A. F., Kloosterman, F. R., Coppens, M., Gouw, S. C., Boyce, S., Bagot, C. N., Beckers, E. A. M., Brons, P., Castaman, G., Eikenboom, J., Jackson, S., Kruip, M. J. H. A., Leebeek, F. W. G., Meijer, K., Nieuwenhuizen, L., Pabinger, I., & Fijnvandraat, K. (2022). Desmopressin for bleeding in non-severe hemophilia A: Suboptimal use in a real-world setting. Research and practice in thrombosis and haemostasis, 6(6), Article e12777. https://doi.org/10.1002/rth2.12777
    • van Balen, E. C., Hassan, S., Smit, C., Driessens, M. H. E., Beckers, E. A. M., Coppens, M., Eikenboom, J. C., Hooimeijer, H. L., Leebeek, F. W. G., Mauser-Bunschoten, E. P., van Vulpen, L. F. D., Schols, S. E. M., Rosendaal, F. R., van der Bom, J. G., & Gouw, S. C. (2022). Socioeconomic participation of persons with hemophilia: Results from the sixth hemophilia in the Netherlands study. Research and practice in thrombosis and haemostasis, 6(6), Article e12741. https://doi.org/10.1002/rth2.12741
    • Kloosterman, F. R., Zwagemaker, A.-F., Bagot, C. N., Beckers, E. A. M., Castaman, G., Cnossen, M. H., Collins, P. W., Hay, C., Hof, M., Laros-van Gorkom, B., Leebeek, F. W. G., Male, C., Meijer, K., Pabinger, I., Shapiro, S., Coppens, M., Fijnvandraat, K., & Gouw, S. C. (2022). The bleeding phenotype in people with nonsevere hemophilia. Blood advances, 6(14), 4256-4265. https://doi.org/10.1182/bloodadvances.2022007620
    • van Lieshout, R., Lize, N., Tick, L. W., van Deursen, J., Driessen, E., Janssen, T., Custers, S., Kranenburg, S., van der Lee, D., Koene, H. R., Beckers, E. A. M., Schouten, H. C., & Beijer, S. (2022). Nutrition-related problems, nutritional support practices and barriers to adherence to nutritional guidelines during intensive treatment for acute myeloid leukemia: Patients' and hematology nurses' perspectives and experiences. Clinical Nutrition ESPEN, 48, 446-455. https://doi.org/10.1016/j.clnesp.2021.12.029
    • Cornelissen, L. L., Kreuger, A. L., Caram-Deelder, C., Huisman, M. V., Middelburg, R. A., Kerkhoffs, J. L. H., von dem Borne, P. A., Beckers, E. A. M., de Vooght, K. M. K., Kuball, J., van der Bom, J. G., & Zwaginga, J. J. (2022). Association between cardiovascular risk factors and intracranial hemorrhage in patients with acute leukemia. European Journal of Haematology, 108(4), 310-318. https://doi.org/10.1111/ejh.13737
    • Heubel-Moenen, F. C. J. I., Brouns, S. L. N., Herfs, L., Boerenkamp, L. S., Jooss, N. J., Wetzels, R. J. H., Verhezen, P. W. M., Machiels, P., Megy, K., Downes, K., Heemskerk, J. W. M., Beckers, E. A. M., & Henskens, Y. M. C. (2022). Multiparameter platelet function analysis of bleeding patients with a prolonged platelet function analyser closure time. British Journal of Haematology, 196(6), 1388-1400. https://doi.org/10.1111/bjh.18003
    • Post, D. S., van der Veer, A., Schijns, O. E. M. G., Klinkenberg, S., Rijkers, K., Wagner, G. L., van Kranen-Mastenbroek, V. H. J. M., Willems, P. C. P. H., Verhezen, P. W. M., Beckers, E. A. M., Heubel-Moenen, F. C. J. I., & Henskens, Y. M. C. (2022). Assessment of need for hemostatic evaluation in patients taking valproic acid: A retrospective cross-sectional study. PLOS ONE, 17(2), Article e0264351. https://doi.org/10.1371/journal.pone.0264351
  • 2021
    • Isfordink, C. J., Gouw, S. C., van Balen, E. C., Hassan, S., Beckers, E. A. M., van der Bom, J. G., Coppens, M., Eikenboom, J., Fischer, K., Hooimeijer, L., Leebeek, F. W. G., Rosendaal, F. R., Schols, S. E. M., Smit, C., van Vulpen, L. F. D., & Mauser-Bunschoten, E. P. (2021). Hepatitis C virus in hemophilia: Health-related quality of life after successful treatment in the sixth Hemophilia in the Netherlands study. Research and practice in thrombosis and haemostasis, 5(8), e12616. Article e12616. https://doi.org/10.1002/rth2.12616
    • van Balen, E. C., Haverman, L., Hassan, S., Taal, E. M., Smit, C., Driessens, M. H., Beckers, E. A. M., Coppens, M., Eikenboom, J., Hooimeijer, H. L., Leebeek, F. W. G., van Vulpen, L. F. D., Schols, S. E. M., Terwee, C. B., Rosendaal, F. R., van der Bom, J. G., & Gouw, S. C. (2021). Validation of PROMIS Profile-29 in adults with hemophilia in the Netherlands. Journal of Thrombosis and Haemostasis, 19(11), 2687-2701. https://doi.org/10.1111/jth.15454
    • Hassan, S., van Balen, E. C., Smit, C., Mauser-Bunschoten, E. P., van Vulpen, L. F. D., Eikenboom, J., Beckers, E. A. M., Hooimeijer, L., Ypma, P. F., Nieuwenhuizen, L., Coppens, M., Schols, S. E. M., Leebeek, F. W. G., Driessens, M. H., Rosendaal, F. R., van der Bom, J. G., & Gouw, S. C. (2021). Health and treatment outcomes of patients with hemophilia in the Netherlands, 1972-2019. Journal of Thrombosis and Haemostasis, 19(10), 2394-2406. https://doi.org/10.1111/jth.15424
    • van Moort, I., Preijers, T., Bukkems, L. H., Hazendonk, H. C. A. M., van der Bom, J. G., Laros-van Gorkom, B. A. P., Beckers, E. A. M., Nieuwenhuizen, L., van der Meer, F. J. M., Ypma, P., Coppens, M., Fijnvandraat, K., Schutgens, R. E. G., Meijer, K., Leebeek, F. W. G., Mathot, R. A. A., Cnossen, M. H., & OPTI-CLOT Study Grp (2021). Perioperative pharmacokinetic-guided factor VIII concentrate dosing in haemophilia (OPTI-CLOT trial): an open-label, multicentre, randomised, controlled trial. The Lancet Haematology, 8(7), E492-E502. https://doi.org/10.1016/S2352-3026(21)00135-6
    • Bukkems, L. H., Heijdra, J. M., de Jager, N. C. B., Hazendonk, H. C. A. M., Fijnvandraat, K., Meijer, K., Eikenboom, J. C. J., Laros-Van Gorkom, B. A. P., Leebeek, F. W. G., Cnossen, M. H., Mathôt, R. A. A., Coppens, K. F. M., Kruip, M. J. H. A., Polinder, S., Lock, J., Hazendonk, H. C. A. M., van Moort, I., Heijdra, J. M., Goedhart, M. C. H. J., ... OPTI-CLOT Study Group (2021). Population pharmacokinetics of the von Willebrand factor-factor VIII interaction in patients with von Willebrand disease. Blood advances, 5(5), 1513-1522. https://doi.org/10.1182/BLOODADVANCES.2020003891
    • Hassan, S., Monahan, R. C., Mauser-Bunschoten, E. P., van Vulpen, L. F. D., Eikenboom, J., Beckers, E. A. M., Hooimeijer, L., Ypma, P. F., Nieuwenhuizen, L., Coppens, M., Schols, S. E. M., Leebeek, F. W. G., Smit, C., Driessens, M. H., le Cessie, S., van Balen, E. C., Rosendaal, F. R., van Der Bom, J. G., & Gouw, S. C. (2021). Mortality, life expectancy, and causes of death of persons with hemophilia in the Netherlands 2001-2018. Journal of Thrombosis and Haemostasis, 19(3), 645-653. https://doi.org/10.1111/jth.15182
    • Cornelissen, L. L., Kreuger, A. L., Caram-Deelder, C., Middelburg, R. A., Kerkhoffs, J. L. H., von dem Borne, P. A., Beckers, E. A. M., de Vooght, K. M. K., Kuball, J., Zwaginga, J. J., & van der Bom, J. G. (2021). Thrombocytopenia and the effect of platelet transfusions on the occurrence of intracranial hemorrhage in patients with acute leukemia - a nested case-control study. Annals of Hematology, 100(1), 261-271. https://doi.org/10.1007/s00277-020-04298-7
    • Schep, S. J., van Dijk, W. E. M., Beckers, E. A. M., Meijer, K., Coppens, M., Eikenboom, J., Leebeek, F. W. G., van Vulpen, L. F. D., Fischer, K. F., Schutgens, R. E. G., & Dutch Society of Haemophilia Treaters (2021). Treatment of acquired hemophilia A, a balancing act: results from a 27-year Dutch cohort study. American Journal of Hematology, 96(1), 51-59. https://doi.org/10.1002/ajh.26009
  • 2020
    • Abdi, A., Kloosterman, F. R., Eckhardt, C. L., Male, C., Castaman, G., Fischer, K., Beckers, E. A. M., Kruip, M. J. H. A., Peerlinck, K., Mancuso, M. E., Santoro, C., Hay, C. R., Platokouki, H., van Der Bom, J. G., Gouw, S. C., Fijnvandraat, K., Hart, D. P., & INSIGHT Study Group (2020). The factor VIII treatment history of non-severe hemophilia A. Journal of Thrombosis and Haemostasis, 18(12), 3203-3210. https://doi.org/10.1111/jth.15076
    • Valke, L. L. F. G., Beckers, E. A. M., Blijlevens, N. M. A., van Heerde, W. L., & Schols, S. E. M. (2020). Effect of emicizumab on thrombin generation: A case report of breakthrough bleeding during emicizumab treatment. Haemophilia, 26(6), E327-E330. https://doi.org/10.1111/hae.14085
    • Blaauwgeers, M. W., Kruip, M. J. H. A., Beckers, E. A. M., Coppens, M., Eikenboom, J., van Galen, K. P. M., Tamminga, R. Y. J., Urbanus, R. T., & Schutgens, R. E. G. (2020). Bleeding phenotype and diagnostic characterization of patients with congenital platelet defects. American Journal of Hematology, 95(10), 1142-1147. https://doi.org/10.1002/ajh.25910
    • Leader, A., ten Cate, V., ten Cate-Hoek, A. J., Beckers, E. A. M., Spectre, G., Giaccherini, C., Gurevich-Shapiro, A., Krashin, E., Raanani, P., Schouten, H. C., Falanga, A., & ten Cate, H. (2020). Anticoagulation in thrombocytopenic patients with hematological malignancy: A multinational clinical vignette-based experiment. European journal of internal medicine, 77, 86-96. https://doi.org/10.1016/j.ejim.2020.03.005
    • Jansen, A. J. G., van den Bosch, J., te Boekhorst, P. A. W., Schipperus, M. R., & Beckers, E. A. M. (2020). Results of the prematurely terminated TEMPLE randomized controlled trial in patients with myelodysplastic syndrome: liberal versus restrictive red blood cell transfusion threshold. Transfusion, 60(4), 879-881. https://doi.org/10.1111/trf.15708
    • Ypma, P. F., van Geloven, N., Kerkhoffs, J. L. H., te Boekhorst, P., Zwaginga, J. J., Beckers, E. A. M., Brand, A., van der Meer, P. F., & Eikenboom, J. C. J. (2020). The association between haemorrhage and markers of endothelial insufficiency and inflammation in patients with hypoproliferative thrombocytopenia: a cohort study. British Journal of Haematology, 189(1), 171-181. https://doi.org/10.1111/bjh.16291
    • Saadah, N. H., Schipperus, M. R., Wiersum-Osselton, J. C., van Kraaij, M. G., Caram-Deelder, C., Beckers, E. A. M., Leyte, A., Rondeel, J. M. M., de Vooght, K. M. K., Weerkamp, F., Zwaginga, J. J., & van der Bom, J. G. (2020). Transition from fresh frozen plasma to solvent/detergent plasma in the Netherlands: comparing clinical use and transfusion reaction risks. Haematologica-the Hematology Journal, 105(4), 1158-1165. https://doi.org/10.3324/haematol.2019.222083
    • van Asten, I., Blaauwgeers, M., Granneman, L., Heijnen, H. F. G., Kruip, M. J. H. A., Beckers, E. A. M., Coppens, M., Eikenboom, J., Tamminga, R. Y. J., Pasterkamp, G., Huisman, A., van Galen, K. P. M., Korporaal, S. J. A., Schutgens, R. E. G., & Urbanus, R. T. (2020). Flow cytometric mepacrine fluorescence can be used for the exclusion of platelet dense granule deficiency. Journal of Thrombosis and Haemostasis, 18(3), 706-713. https://doi.org/10.1111/jth.14698
    • Blaauwgeers, M. W., Kruip, M. J. H. A., Beckers, E. A. M., Coppens, M., Eikenboom, J., van Galen, K. P. M., Tamminga, R. Y. J., Urbanus, R. T., Schutgens, R. E. G., & TiN Study Group (2020). Congenital platelet disorders and health status-related quality of life. Research and practice in thrombosis and haemostasis, 4(1), 100-105. https://doi.org/10.1002/rth2.12281
    • Blaauwgeers, M. W., van Asten, I., Kruip, M. J. H. A., Beckers, E. A. M., Coppens, M., Eikenboom, J., van Galen, K. P. M., Huisman, A., Korporaal, S. J. A., Ploos van Amstel, H. K., Tamminga, R. Y. J., Urbanus, R. T., & Schutgens, R. E. G. (2020). The limitation of genetic testing in diagnosing patients suspected for congenital platelet defects. American Journal of Hematology, 95(1), E26-E28. https://doi.org/10.1002/ajh.25667
  • 2019
    • Heubel-Moenen, F. C. J. I., Henskens, Y. M. C., Verhezen, P. W. M., Wetzels, R. J. H., Schouten, H. C., & Beckers, E. A. M. (2019). Fibrinolysis in patients with chemotherapy-induced thrombocytopenia and the effect of platelet transfusion. Journal of Thrombosis and Haemostasis, 17(7), 1073-1084. https://doi.org/10.1111/jth.14465
    • Schutte, L. M., Cnossen, M. H., van Hest, R. M., Driessens, M. H. E., Fijnvandraat, K., Polinder, S., Beckers, E. A. M., Coppens, M., Eikenboom, J., Gorkom, B. A. P. L., Meijer, K., Nieuwenhuizen, L., Mauser-Bunschoten, E. P., Leebeek, F. W. G., Mathot, R. A. A., & Kruip, M. J. H. A. (2019). Desmopressin treatment combined with clotting factor VIII concentrates in patients with non-severe haemophilia A: protocol for a multicentre single-armed trial, the DAVID study. BMJ Open, 9(4), Article 022719. https://doi.org/10.1136/bmjopen-2018-022719
    • Mueller, M. M., Van Remoortel, H., Meybohm, P., Aranko, K., Aubron, C., Burger, R., Carson, J. L., Cichutek, K., De Buck, E., Devine, D., Fergusson, D., Folléa, G., French, C., Frey, K. P., Gammon, R., Levy, J. H., Murphy, M. F., Ozier, Y., Pavenski, K., ... ICC PBM Frankfurt 2018 Group (2019). Patient Blood Management: Recommendations from the 2018 Frankfurt Consensus Conference. JAMA-Journal of the American Medical Association, 321(10), 983-997. https://doi.org/10.1001/jama.2019.0554
    • Moenen, F. C. J., Vries, M. J. A., Nelemans, P. J., van Rooy, K. J. M., Vranken, J. R. R. A., Verhezen, P. W. M., Wetzels, R. J. H., ten Cate, H., Schouten, H. C., Beckers, E. A. M., & Henskens, Y. M. C. (2019). Screening for platelet function disorders with Multiplate and platelet function analyzer. Platelets, 30(1), 81-87. https://doi.org/10.1080/09537104.2017.1371290
    • Leader, A., Ten Cate, V., Ten Cate-Hoek, A. J., Spectre, G., Beckers, E. A. M., Raanani, P., Giaccherini, C., Pereg, D., Schouten, H. C., Falanga, A., & Ten Cate, H. (2019). Managing Anti-Platelet Therapy in Thrombocytopaenic Patients with Haematological Malignancy: A Multinational Clinical Vignette-Based Experiment. Thrombosis and Haemostasis, 119(1), 163-174. https://doi.org/10.1055/s-0038-1676520
    • Atiq, F., Mauser-Bunschoten, E. P., Eikenboom, J., van Galen, K. P. M., Meijer, K., de Meris, J., Cnossen, M. H., Beckers, E. A. M., Laros-van Gorkom, B. A. P., Nieuwenhuizen, L., van der Bom, J. G., Fijnvandraat, K., Leebeek, F. W. G., & WiN Study Group (2019). Sports participation and physical activity in patients with von Willebrand disease. Haemophilia, 25(1), 101-108. https://doi.org/10.1111/hae.13629
  • 2018
    • Leader, A., ten Cate, H., Spectre, G., Beckers, E. A. M., & Falanga, A. (2018). Antithrombotic medication in cancer-associated thrombocytopenia: Current evidence and knowledge gaps. Critical Reviews in Oncology/Hematology, 132, 76-88. https://doi.org/10.1016/j.critrevonc.2018.09.014
    • Bosboom, J. J., Klanderman, R. B., Peters, A. L., van de Weerdt, E. K., Goudswaard, E. J., Binnekade, J. M., Zwaginga, J. J., Beckers, E. A. M., Geerts, B. F., Hollmann, M. W., Zeerleder, S. S., van Kraaij, M., & Vlaar, A. P. (2018). The practice of diagnosing and reporting transfusion-associated circulatory overload: a national survey among physicians and haemovigilance officers. Transfusion Medicine, 28(5), 363-370. https://doi.org/10.1111/tme.12480
    • Baaten, C. C. F. M. J., Moenen, F. C. J. I., Henskens, Y. M. C., Swieringa, F., Wetzels, R. J. H., van Oerle, R., Heijnen, H. F. G., ten Cate, H., Holloway, G. P., Beckers, E. A. M., Heemskerk, J. W. M., & van der Meijden, P. E. J. (2018). Impaired mitochondrial activity explains platelet dysfunction in thrombocytopenic cancer patients undergoing chemotherapy. Haematologica-the Hematology Journal, 103(9), 1557-1567. https://doi.org/10.3324/haematol.2017.185165
    • Kreuger, A. L., Middelburg, R. A., Beckers, E. A. M., de Vooght, K. M. K., Zwaginga, J. J., Kerkhoffs, J.-L. H., & van der Bom, J. G. (2018). The identification of cases of major hemorrhage during hospitalization in patients with acute leukemia using routinely recorded healthcare data. PLOS ONE, 13(8), Article e0200655. https://doi.org/10.1371/journal.pone.0200655
    • van der Meer, P. F., Ypma, P. F., van Geloven, N., van Hilten, J. A., van Wordragen-Vlaswinkel, R. J., Eissen, O., Zwaginga, J. J., Trus, M., Beckers, E. A. M., te Boekhorst, P., Tinmouth, A., Lin, Y., Hsia, C., Lee, D., Norris, P. J., Goodrich, R. P., Brand, A., Hervig, T., Heddle, N. M., ... Kerkhoffs, J.-L. H. (2018). Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trial. Blood, 132(2), 223-231. https://doi.org/10.1182/blood-2018-02-831289
    • Moenen, F. C. J. I., Nelemans, P. J., Schols, S. E. M., Schouten, H. C., Henskens, Y. M. C., & Beckers, E. A. M. (2018). The diagnostic accuracy of bleeding assessment tools for the identification of patients with mild bleeding disorders: A systematic review. Haemophilia, 24(4), 525-535. https://doi.org/10.1111/hae.13486
Overview